During the past two decades, recombinant DNA technology brought about a significant increase in the number of protein drugs. The development of analytical techniques enables a high degree of clarification of the recombinant proteins, which in turn, brings about a significant decrease of the adverse effects. In spite of that, one of the capital problems, and challenges in the development of protein pharmaceuticals remains unsolved: the physical and chemical instability/degradation of proteins, which... Mehr